Stockscreener 앱 받기
80.94
1.84%
-1.52
시장 영업 전:
81.39
0.45
+0.56%
Solventum Corp 주식(SOLV)의 최신 뉴스
Daily Brief Health Care: Laurus Labs, Ascendis Pharma, GSK , Incyte Corp, Insmed Inc, Johnson & Johnson, Kardigan, LogicMark, Parabilis Medicines, Solventum and more - Smartkarma
The future of clear aligners: how Clarity Aligners from Solventum can improve treatment precision - Digital Journal
Solventum Corp. stock rises Tuesday, outperforms market - MarketWatch
3M Company stock (US88579Y1010): Spin-off hangover and legal risks keep investors on edge - AD HOC NEWS
3M Company stock (US88579Y1010): Board shake-up and post-spin future after Solventum deal - AD HOC NEWS
Why Solventum Stock Is Sinking Despite Strong Earnings - TipRanks
Solventum trends for 2026: AI coding, tariffs, and margins - MSN
Solventum Corp. stock falls Monday, underperforms market - MarketWatch
3M Company stock (US88579Y1010): Spin-off of Solventum reshapes the conglomerate - AD HOC NEWS
Solventum Trends for 2026: AI Coding, Tariffs, and Margins - Zacks Investment Research
Q1 Earnings Roundup: Solventum (NYSE:SOLV) And The Rest Of The Surgical Equipment & ConsumablesDiversified Segment - StockStory
Is Solventum’s (SOLV) Governance Tweaks Hinting At How It Will Navigate AI Disruption? - Yahoo Finance
Assessing Solventum (SOLV) Valuation As AI Disruption Fears Challenge Health Information Systems Prospects - simplywall.st
AI Models Turn More Constructive on Solventum (SOLV) as Profitability and Valuation Stand Out - TipRanks
Solventum (SOLV) Q1 2026 Earnings Transcript - AOL.com
Solventum Corporation 8-K Filing: Company Details, Address, Ticker, and Exchange Information (June 2, 2026) - minichart.com.sg
Solventum (SOLV) Q1 2026 Earnings Call Transcript - Fortune
Why Solventum (SOLV) Is Up 8.1% After Q1 Beat And $1 Billion Buyback Announcement - Sahm
Solventum Corp. stock rises Thursday, outperforms market - MSN
Solventum Resolves Bylaw Litigation and Case Closed - TipRanks
Solventum Corp. stock outperforms market despite losses on the day - MarketWatch
Solventum (NYSE: SOLV) closes By-law challenge with $120K mootness fee payment - Stock Titan
Solventum executive pay disclosure includes $11M severance for ex-MedSurg leader - Medical Design & Outsourcing
Solventum Corporation (SOLV) Fell as Its HCIT Unit Hurt by AI Disruption Fears - Yahoo Finance
Executives at Solventum commute to Minnesota by plane. A shareholder wants to change that - MSN
Solventum Corp. stock rises Wednesday, outperforms market - MarketWatch
SOLV Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Solventum Corp. stock rises Monday, outperforms market - MarketWatch
Solventum Corporation (SOLV) Stock Analysis: Strong Return on Equity and Investor Ratings Signal Potential Growth - DirectorsTalk Interviews
3M Company stock (US88579Y1010): technical picture in focus after Solventum spin-off and PFAS headli - AD HOC NEWS
3M Company stock (US88579Y1010): shares react to recent spin-off of Solventum and technical picture - AD HOC NEWS
Solventum (SOLV) recently broke out above the 200-day moving average - MSN
Solventum Corp. stock falls Friday, underperforms market - MarketWatch
Trian Presses Solventum Over Private‑Jet Exec Commutes - Hoodline
Minnesota’s Solventum to pay $1.6M fine for selling equipment to Chinese firms - MSN
Executives at this Minnesota company commute here by plane. A shareholder wants to change that. - Star Tribune
Solventum (SOLV) Q4 2025 Earnings Call Transcript - Fortune
Solventum Adopts Updated Executive Severance and Compensation Plan - The Globe and Mail
Solventum Corporation 8-K Filing: Executive Severance Plan, Key Company Information & NYSE Listing (2026) - Minichart
Executive severance revised at Solventum (NYSE: SOLV) with new pay and benefits - Stock Titan
Solventum to Participate in the 2026 Jefferies Healthcare Conference - PR Newswire
Goldman Sachs Adjusts Price Target on Solventum to $67 From $66, Maintains Sell Rating - marketscreener.com
3M Company stock (US88579Y1010): Spin-off of Solventum reshapes the industrial giant - AD HOC NEWS
Analysts Offer Insights on Healthcare Companies: Bristol-Myers Squibb (BMY), BillionToOne, Inc. Class A (BLLN) and Solventum Corporation (SOLV) - The Globe and Mail
Solventum Beats Consensus Estimates for 1Q26 - Medical Device and Diagnostic industry
Solventum Corporation (SOLV) Stock Report: Is A 6.83% Upside Worth The Dive? - DirectorsTalk Interviews
3M Company stock (US88579Y1010): spin-off, earnings pressure and legal risks in focus - AD HOC NEWS
Assessing Solventum (SOLV) Valuation As Recent Momentum Meets Perceived Undervaluation - simplywall.st
Solventum stock is recovering: What's going on? - MSN
3M Company stock (US88579Y1010): Q1 2026 earnings and Solventum spin-off reshape the industrial gian - AD HOC NEWS
Solventum Shareholders Back Board, Pay and Auditor Choices - TipRanks
Solventum (NYSE: SOLV) shareholders approve directors, pay plan and PwC auditor - Stock Titan
Solventum Corp. stock falls Tuesday, underperforms market - MarketWatch
What Are Wall Street Analysts' Target Price for Solventum Stock? - Barchart
Will Activist Pressure and Reaffirmed EPS Guidance Reshape Solventum's (SOLV) Transformation Narrative? - simplywall.st
Solventum gains after activist Trian sends letter urging changes (update) - MSN
Solventum (SOLV) director Carlos Alban receives 3,300 restricted stock units - Stock Titan
Solventum Corp (SOLV) director receives 4,848 restricted stock units - Stock Titan
1.36%
1.40%
자본화:
|
볼륨(24시간):